A standard heparin nomogram for the management of heparin therapy.

A nomogram for the adjustment of heparin dosage was developed to standardize heparin therapy and to reduce delays in achieving and maintaining a therapeutic activated partial thromboplastin time (APTT) result. Fifty consecutive patients with acute venous thromboembolism had their continuous intravenous heparin therapy adjusted according to this heparin nomogram. The effect of the nomogram on heparin therapy in these patients was compared with data from 53 historical control patients. The proportion of patients in the nomogram group who reached a therapeutic APTT at 24 hours after the start of heparin therapy was 66%, which increased to 81% at 48 hours. In contrast, 37% and 58% of the control patients reached a therapeutic APTT at 24 and 48 hours, respectively. The percentage of therapeutic APTT results of the total number of APTT determinations was greater in the nomogram patients than controls. The use of this heparin nomogram resulted in (1) achieving a therapeutic APTT at 24 and 48 hours in a large proportion of patients and (2) reduced periods of inadequate anticoagulation and overanticoagulation during heparin therapy.

[1]  A. Fennerty,et al.  Non-biological factors in day to day variation of heparin requirements. , 1989, BMJ.

[2]  J. Newman,et al.  Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. , 1988, Archives of internal medicine.

[3]  G. Raskob,et al.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. , 1986, The New England journal of medicine.

[4]  J. Hirsh,et al.  Hemorrhagic Complications of Anticoagulant Therapy , 1986, Seminars in thrombosis and hemostasis.

[5]  P. Routledge,et al.  Audit of control of heparin treatment. , 1985, British medical journal.

[6]  W. Grove Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[7]  J. Hirsh,et al.  Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. , 1977, Blood.

[8]  C. Dollery,et al.  Heparin Kinetics in Venous Thrombosis and Pulmonary Embolism , 1976, Circulation.

[9]  E W Salzman,et al.  Management of heparin therapy: Controlled prospective trial. , 1975, The New England journal of medicine.

[10]  J. Fleiss,et al.  Statistical methods for rates and proportions , 1973 .

[11]  J. Hirsh,et al.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. , 1972, The New England journal of medicine.

[12]  N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.

[13]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .